DeepMed Research

UNIVERSITY OF SYDNEY

🇦🇺Australia

Country: 🇦🇺Australia

Ownership: -

Established: 1850-01-01

Employees: -

Market Cap: -

Website: https://www.sydney.edu.au/

Clinical Trials

A Study of Low-dose Intracoronary Thrombolytic Therapy in STEMI (Heart Attack) Patients.

Phase 3

Recruiting

Conditions: Elevated IMR (>32)
STEMI

Interventions: Drug: Tenecteplase (1/3 systemic weight based dose)
Other: Sterile water for injection (WFI)

First Posted Date: 2019-06-26

Last Posted Date: 2023-10-30

Lead Sponsor: University of Sydney

Target Recruit Count: 445

Registration Number: NCT03998319

Locations: 🇦🇺
Victorian Heart Hospital, Clayton, Victoria, Australia
🇦🇺
Bankstown-Lidcombe Hospital, Bankstown, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia

and more 19 locations

Non Small Cell Lung Cancer Trial of Durvalumab and Tremelimumab in Advanced Epidermal Growth Factor Receptor (EGFR) Mutant Disease.

Phase 2

Active, not recruiting

Conditions: EGFR Mutant Advanced Non Small Cell Lung Cancer

Interventions: Drug: Tremelimumab
Drug: Durvalumab

First Posted Date: 2019-06-21

Last Posted Date: 2023-04-21

Lead Sponsor: University of Sydney

Target Recruit Count: 100

Registration Number: NCT03994393

Locations: 🇦🇺
Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia
🇦🇺
St Vincent's Hospital (Melbourne), Melbourne, Victoria, Australia
🇨🇳
Taiwan Dalin Tzu Chi Hospital, Chiayi City, Taiwan

and more 13 locations

Patient-led Surveillance Compared to Clinician-led Surveillance in People Treated for Localised Melanoma.

Not Applicable

Completed

Conditions: Melanoma (Skin)

Interventions: Behavioral: Clinician-led surveillance
Device: Patient-led surveillance

First Posted Date: 2018-07-10

Last Posted Date: 2023-08-01

Lead Sponsor: University of Sydney

Target Recruit Count: 100

Registration Number: NCT03581188

Locations: 🇦🇺
Newcastle Skin Check, Newcastle, New South Wales, Australia
🇦🇺
Melanoma Institute Australia, North Sydney, New South Wales, Australia
🇦🇺
Royal Prince Alfred Hospital, Sydney, New South Wales, Australia

Composition of Functional Tooth Units and Nutrient Intake in Older Men

Completed

Conditions: Dietary Assessment of Older Men
Oral Health of Older Men

First Posted Date: 2017-09-27

Last Posted Date: 2017-09-27

Lead Sponsor: University of Sydney

Target Recruit Count: 781

Registration Number: NCT03295435

Locations: 🇦🇺
The Centre for Education and Research on Ageing, Sydney, New South Wales, Australia

Evaluation of a Patient-Reported Symptom Index for NMIBC

Completed

Conditions: Superficial Bladder Cancer

First Posted Date: 2017-03-27

Last Posted Date: 2021-10-13

Lead Sponsor: University of Sydney

Target Recruit Count: 498

Registration Number: NCT03091764

Locations: 🇦🇺
Royal North Shore Hospital, St Leonards, New South Wales, Australia
🇺🇸
University of Kansas, Kansas City, Kansas, United States
🇦🇺
Concord Hospital, Concord, New South Wales, Australia

and more 16 locations

Prophylactic Early PN in HPT/BMT

Not Applicable

Conditions: Hematologic Neoplasms

Interventions: Dietary Supplement: Parenteral nutrition.
Other: Pragmatic standard care.

First Posted Date: 2017-03-20

Last Posted Date: 2021-04-28

Lead Sponsor: University of Sydney

Target Recruit Count: 408

Registration Number: NCT03083327

Locations: 🇦🇺
Royal North Shore Hospital, Sydney, New South Wales, Australia
🇦🇺
Royal Adelaide Hospital, Adelaide, South Australia, Australia
🇳🇿
Christchurch Hospital, CDHB, Christchurch, New Zealand

PAEAN - Erythropoietin for Hypoxic Ischaemic Encephalopathy in Newborns

Phase 3

Completed

Conditions: Hypoxic-Ischemic Encephalopathy

Interventions: Drug: Epoetin Alfa
Drug: Normal saline

First Posted Date: 2017-03-14

Last Posted Date: 2024-06-05

Lead Sponsor: University of Sydney

Target Recruit Count: 313

Registration Number: NCT03079167

Locations: 🇦🇺
Flinders Medical Centre, Bedford Park, South Australia, Australia
🇦🇺
The Royal Women's Hospital, Parkville, Victoria, Australia
🇸🇬
KK Women's and Children's Hospital, Singapore, Singapore

and more 21 locations

Patient Experience and Acceptance of Horizontal Rotation

Not Applicable

Recruiting

Conditions: Cancer

Interventions: Device: Nano-X patient rotation

First Posted Date: 2016-12-16

Last Posted Date: 2024-07-03

Lead Sponsor: University of Sydney

Target Recruit Count: 100

Registration Number: NCT02995603

Locations: 🇦🇺
Prince of Wales Hospital, Randwick, New South Wales, Australia

Liver Ablative Radiotherapy Utilising Kilovoltage Intrafraction Monitoring (KIM)

Not Applicable

Active, not recruiting

Conditions: Liver Cancer

Interventions: Device: Kilovoltage Intrafraction Monitoring

First Posted Date: 2016-12-07

Last Posted Date: 2025-04-04

Lead Sponsor: University of Sydney

Target Recruit Count: 32

Registration Number: NCT02984566

Locations: 🇦🇺
Westmead Hospital, Westmead, New South Wales, Australia
🇦🇺
Princess Alexandra Hospital, Woolloongabba, Queensland, Australia
🇦🇺
Nepean Hospital, Penrith, New South Wales, Australia

and more 1 locations

Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer

Phase 3

Active, not recruiting

Conditions: Bladder Cancer

Interventions: Biological: Bacillus of Calmette-Guerin (BCG)
Drug: Mitomycin (MM)

First Posted Date: 2016-10-28

Last Posted Date: 2023-06-18

Lead Sponsor: University of Sydney

Target Recruit Count: 501

Registration Number: NCT02948543

Locations: 🇬🇧
Nottingham City Hospital - City Campus, Nottingham, United Kingdom
🇦🇺
Fiona Stanley Hospital, Murdoch, Western Australia, Australia
🇦🇺
Concord Repatriation General Hospital, Concord, New South Wales, Australia

and more 14 locations

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy